Combining Pharmaceutical and Functional Medicine Approaches in COVID-19

This presentation will thoroughly review pharmaceutical and function medicine options to treat COVID-19. This presentation will also go over other advanced therapeutics to help prevent and manage complex COVID-19 cases.

The objectives include:

Review risk factors for COVID-19 and the interaction of the microbiome, biofilm, and hidden pathogens.
Post-COVID issues related to resurgence of hidden infections.
Pharmaceutical drug-induced nutritional depletion and increased risk factors for COVID-19.
Outlining of pharmaceutical/functional approach to the treatment of COVID-19.
Review advanced therapeutic options and experimental options to the treatment of COVID-19.

John Kim, PharmD, FAARFM is a compounding pharmacist and an owner of Robinson Drug & Compounding Center. Dr. Kim specializes in functional medicine, pain management, vector borne illness (ie: Lyme disease and opportunistic infections), autoimmune disorder, and chronic fatigue disorder. Dr. Kim has been one of the outspoken experts in managing COIVD-19 as an outpatient with early adoption of using hydroxychloroquine, Ivermectin, low dose naltrexone, and other therapeutics.